Medicine

Medical News | Medicine
Metabolic Optimization & Longevity: A Paradigm Shift from Rapid Weight-Loss Diets to Lifelong Metabolic Health, Brain Optimization, and Cognitive Resilience
Bydoctorcostamed May 20, 2026May 20, 2026
Introduction: The End of the Diet Era—and the Rise of Metabolic Intelligence For decades, public health messaging centered on rapid weight loss as the primary metric of health improvement. Diets—from Atkins to Keto to intermittent fasting (IF) fads—promised swift results but often ignored underlying metabolic dysfunction. The result? A cycle of weight cycling (weight yo-yoing),…
Read More Metabolic Optimization & Longevity: A Paradigm Shift from Rapid Weight-Loss Diets to Lifelong Metabolic Health, Brain Optimization, and Cognitive Resilience
Medical News | Medicine
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Mechanisms, Clinical Efficacy in Weight Management, and Clinical Implications
Bydoctorcostamed May 20, 2026May 20, 2026
Executive Summary GLP-1 receptor agonists (GLP-1 RAs) represent a transformative class of incretin-based therapeutics originally developed for type 2 diabetes (T2D), now proven to yield robust, clinically meaningful weight loss. Mechanisms extend beyond glycemic control to include central appetite suppression, delayed gastric emptying, and modulation of energy expenditure. High-evidence data—from phase 3 randomized controlled trials…
Read More Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Mechanisms, Clinical Efficacy in Weight Management, and Clinical Implications
Medicine
In Vitro Fertilization (IVF): A Comprehensive Guide
Bydoctorcostamed May 4, 2026May 4, 2026
Introduction In vitro fertilization (IVF) is one of the most advanced and widely used assisted reproductive technologies (ARTs) to help individuals and couples conceive when natural conception is not possible. Since its first successful application in 1978, IVF has revolutionized reproductive medicine, offering hope to millions facing infertility challenges. This article explores what IVF is,…
Read More In Vitro Fertilization (IVF): A Comprehensive Guide
Medicine
Achalasia: Comprehensive Clinical Review with Evidence-Based Management Strategies
Bydoctorcostamed April 24, 2026April 24, 2026
Pathophysiology & Diagnostic Criteria Achalasia is a primary esophageal motility disorder rooted in neurodegenerative loss of inhibitory neurons (primarily nitric oxide– and VIP-producing) in the myenteric plexus of the lower esophageal sphincter (LES) and body. This results in: Key pathophysiological insight: The neurodegeneration is focal to the esophagus in classic achalasia, distinguishing it from pseudoachalasia…
Read More Achalasia: Comprehensive Clinical Review with Evidence-Based Management Strategies
Medicine
Acute Cholangitis: Clinical Recognition, Severity Stratification, and Evidence-Based Management
Bydoctorcostamed April 24, 2026April 24, 2026
Pathophysiology & Clinical Context Acute cholangitis is an acute bacterial infection of the biliary tree secondary to biliary obstruction (most commonly choledocholithiasis), leading to stasis, ascending infection, and systemic inflammation. The classic Charcot’s triad (fever, RUQ pain, jaundice) occurs in only 50–70% of cases; the presence of Reynolds’ pentad (adding hypotension and altered mental status)…
Read More Acute Cholangitis: Clinical Recognition, Severity Stratification, and Evidence-Based Management
Medicine
Acute Pancreatitis: Clinical Evaluation, Risk Stratification, and Evidence-Based Management
Bydoctorcostamed April 24, 2026April 24, 2026
Definition & Pathophysiology Acute pancreatitis (AP) is an acute inflammatory process of the pancreas, characterized by autodigestion of pancreatic tissue due to premature activation of pancreatic enzymes (e.g., trypsinogen → trypsin), leading to local injury and systemic inflammation. This triggers a cascade involving cytokine release, complement activation, oxidative stress, and microvascular thrombosis—culminating in potentially life-threatening…
Read More Acute Pancreatitis: Clinical Evaluation, Risk Stratification, and Evidence-Based Management
Medicine
Chronic Pancreatitis: A Clinically Oriented Review with Emphasis on Diagnosis, Etiologic Workup, Complications, and Evidence-Based Management
Bydoctorcostamed April 24, 2026April 24, 2026
Pathophysiology Overview Chronic pancreatitis (CP) is a progressive, irreversible inflammatory pancreatic disorder characterized histopathologically by: The “fibroobstructive” phenotype dominates in most etiologies—particularly hereditary pancreatitis (HP)—where ductal obstruction from stones or strictures drives both inflammation and pain. In contrast, autoimmune pancreatitis (AIP) manifests as an immune-mediated inflammatory process with responsive fibrosis. I. Clinical Presentation & Diagnostic…
Read More Chronic Pancreatitis: A Clinically Oriented Review with Emphasis on Diagnosis, Etiologic Workup, Complications, and Evidence-Based Management
Medicine
Gastroesophageal Reflux Disease (GERD) – Diagnosis, Evaluation, and Management Based on Current Evidence-Based Guidelines
Bydoctorcostamed April 24, 2026April 24, 2026
Definition & Pathophysiology GERD is a chronic, often relapsing disorder characterized by the reflux of gastric (and duodenal) contents—acid, bile, pepsin, and pancreatic enzymes—into the esophagus, pharynx, or larynx, resulting in: Key pathophysiological mechanisms include: Epidemiology & Risk Factors Clinical Presentation & Symptom Profile Typical Esophageal Symptoms Atypical/Extraesophageal Symptoms (Controversial association—require rigorous evaluation) Symptom Evidence Strength…
Read More Gastroesophageal Reflux Disease (GERD) – Diagnosis, Evaluation, and Management Based on Current Evidence-Based Guidelines
Medicine
Peptic Ulcer Disease – Pathophysiology, Diagnosis, and Evidence-Based Management
Bydoctorcostamed April 24, 2026April 24, 2026
I. Definition & Pathophysiology Peptic ulcer disease (PUD) is characterized by localized defects in the gastroduodenal mucosa that extend through the muscularis mucosae, resulting from an imbalance between aggressive factors (e.g., gastric acid, pepsin, Helicobacter pylori virulence factors) and defensive mechanisms (e.g., mucus-bicarbonate barrier, mucosal blood flow, epithelial restitution, prostaglandin synthesis). Key pathophysiiological insights: II….
Read More Peptic Ulcer Disease – Pathophysiology, Diagnosis, and Evidence-Based Management
Medicine
Evaluation and Management of Splenomegaly in Children—Integrating Current Evidence-Based Guidelines
Bydoctorcostamed April 24, 2026April 24, 2026
I. Definition & Epidemiologic Context Splenomegaly is defined as a spleen that exceeds the 95th percentile for age- and sex-matched controls—typically: Splenomegaly is a sign, not a diagnosis, reflecting underlying pathology. Its prevalence varies by etiology: up to 50% in acute Epstein–Barr virus (EBV) mononucleosis, 30–40% in sickle cell disease (SCD), and <2% in asymptomatic…
Read More Evaluation and Management of Splenomegaly in Children—Integrating Current Evidence-Based Guidelines
Medicine
Insulinoma — Diagnosis, Localization, Genetic Evaluation, and Management Based on Current Evidence and Guidelines
Bydoctorcostamed April 24, 2026April 24, 2026
Epidemiology and Pathophysiology Insulinomas are rare, typically benign (85–90%), functioning pancreatic neuroendocrine tumors (pNETs) arising from β-cells of the islets of Langerhans. Incidence is ~1–2 cases per million person-years, with a bimodal age distribution (peak incidence: 40–60 years), slight female predominance (F:M ≈ 2:3), and no racial predilection. Most are sporadic (95%); the remaining 5%…
Read More Insulinoma — Diagnosis, Localization, Genetic Evaluation, and Management Based on Current Evidence and Guidelines
Medicine
Hepatitis A Virus (HAV) Infection: Pathogenesis, Diagnosis, Management, and Prevention — Aligning with Current Guidelines and Evidence
Bydoctorcostamed April 24, 2026April 24, 2026
Epidemiology and Burden of Disease Hepatitis A virus (HAV), a non-enveloped, positive-sense single-stranded RNA virus belonging to the Picornaviridae family (genus Orthohepatovirus), remains one of the most prevalent causes of acute viral hepatitis globally. According to WHO estimates, ~1.4 million symptomatic cases occur annually, though seroprevalence studies suggest that up to 80% of infections in…
Read More Hepatitis A Virus (HAV) Infection: Pathogenesis, Diagnosis, Management, and Prevention — Aligning with Current Guidelines and Evidence
Medicine
Hepatitis E Virus (HEV) Infection — Epidemiology, Diagnosis, and Management with Emphasis on Current Guidelines and Evidence-Based Approaches
Bydoctorcostamed April 24, 2026April 24, 2026
Epidemiology and Global Burden Hepatitis E virus (HEV), a non-enveloped, positive-sense, single-stranded RNA virus belonging to the Hepeviridae family (genus Orthohepevirus, species HEV-A), is a globally significant cause of acute viral hepatitis. According to the WHO, HEV causes an estimated 20 million infections annually, resulting in 3.3 million symptomatic cases and over 44,000 deaths—primarily due…
Read More Hepatitis E Virus (HEV) Infection — Epidemiology, Diagnosis, and Management with Emphasis on Current Guidelines and Evidence-Based Approaches
Medicine
Acute Hepatitis B Virus (HBV) Infection — Diagnosis, Risk Stratification, Management, and Transition to Chronic Disease
Bydoctorcostamed April 24, 2026April 24, 2026
Authored for clinicians with emphasis on evidence-based practice, updated guidelines (AASLD 2018, EASL 2017/2024 updates), and practical decision-making tools. Epidemiology & Virology Primer (Clinician Refresher) HBV is a Hepadnaviridae family, enveloped virus with a partially double-stranded, relaxed circular DNA genome. It replicates via an RNA intermediate using a viral reverse transcriptase — a feature conferring…
Read More Acute Hepatitis B Virus (HBV) Infection — Diagnosis, Risk Stratification, Management, and Transition to Chronic Disease
Medicine
Diagnosis and Management of Chronic Constipation in Adults – An Evidence-Based Perspective for Clinicians
Bydoctorcostamed April 24, 2026April 24, 2026
Epidemiology and Clinical Significance Chronic functional constipation (CFC) affects approximately 12–27% of the general adult population, with prevalence rising sharply with age—up to 30–40% in individuals ≥65 years. It is more common in women (female-to-male ratio ~1.7:1), socioeconomic disadvantage, and sedentary lifestyle. Beyond reduced quality of life, constipation contributes significantly to healthcare utilization—accounting for over…
Read More Diagnosis and Management of Chronic Constipation in Adults – An Evidence-Based Perspective for Clinicians